PMID: 25735391Mar 5, 2015Paper

Prognostic factors influencing clinical outcomes of malignant glioblastoma multiforme: clinical, immunophenotypic, and fluorescence in situ hybridization findings for 1p19q in 816 chinese cases

Asian Pacific Journal of Cancer Prevention : APJCP
Jun-Jie QinGui-Lin Li

Abstract

Malignant glioblastoma multiforme (GBM) is the most malignant brain tumor and despite recent advances in diagnostics and treatment prognosis remains poor. In this retrospective study, we assessed the clinical and radiological parameters, as well as fluorescence in situ hybridization (FISH) of 1p19q deletion, in a series of cases. A total of 816 patients with GBM who received surgery and radiation between January 2010 and May 2014 were included in this study. Kaplan-Meier survival analysis and Cox regression analysis were used to find the factors independently influencing patient progression free survival (PFS) and overall survival (OS). Age at diagnosis, preoperative Karnofsky Performance Scale (KPS) score, KPS score change at 2 weeks after operation, neurological deficit symptoms, tumor resection extent, maximal tumor diameter, involvement of eloquent cortex or deep structure, involvement of brain lobe, Ki-67 and MMP9 expression level and adjuvant chemotherapy were statistically significant factors (p<0.05) for both PFS and OS in the univariate analysis. Cox proportional hazards modeling revealed that age ≤50 years, preoperative KPS score ≥80, KPS score change after operation ≥0, involvement of single frontal lobe, deep struct...Continue Reading

References

Jul 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R MacdonaldJ G Cairncross
Sep 2, 1999·Journal of Neurosurgery·K TaniguchiJ Yoshida
Mar 7, 2000·Frontiers in Bioscience : a Journal and Virtual Library·J S Smith, R B Jenkins
Jun 28, 2000·Cancer·P Kleihues, L H Sobin
May 5, 2001·Brain Research. Brain Research Reviews·M Bredel
Jan 24, 2003·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Johannes LutterbachRoland Guttenberger
Mar 12, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K ParkS Han
Apr 8, 2003·Anti-cancer Drugs·Barbara Fazeny-DörnerChristine Marosi
Jul 2, 2003·Nature Reviews. Cancer·Jasti S Rao
Jul 29, 2003·Journal of Cancer Research and Clinical Oncology·Branislav JeremicJasna Aleksandrovic
Sep 25, 2003·Acta neurochirurgica·N LevicarR K Nutall
Dec 16, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A WeltU Vanhoefer
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jun 4, 2005·Onkologie·Roger Stupp, Damien C Weber
Nov 17, 2005·Nature Reviews. Neuroscience·V Wee Yong
Jan 31, 2006·Neuro-oncology·Sara HoffmanBridget J McCarthy
Feb 16, 2006·The Oncologist·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jul 13, 2006·Expert Review of Anticancer Therapy·Sith Sathornsumetee, Jeremy N Rich
Aug 18, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrick Y WenMichael D Prados
Jun 15, 2007·Journal of the National Cancer Institute·Samuel S M NgMarie C Lin
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Nov 28, 2007·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Marc D PirothMichael J Eble
May 29, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Shu-Dong ChenHui-Sheng Yuan
Jul 28, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Jie JinXue-Song Zhou
Jan 1, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Waraporn YahayoRoongtawan Supabphol
Jan 1, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Sara DarakhshanAli Ghanbari
Mar 4, 2014·Radiology and Oncology·Uros SmrdelMatjaz Zwitter
Mar 13, 2014·Neurology India·Vandita Y SinghVedantam Rajshekhar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.